Close Menu

NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues declined 10 percent year over year.

For the three months ended September 30, the Temple City, California-based genetic testing firm reported revenues of $4.5 million compared to $5.0 million in the prior-year quarter, short of analysts' average estimate of $5.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.